Form 8-K - Current report:
SEC Accession No. 0000950170-25-072700
Filing Date
2025-05-15
Accepted
2025-05-15 16:23:51
Documents
19
Period of Report
2025-05-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hcwb-20250513.htm   iXBRL 8-K 57486
2 EX-4.1 hcwb-ex4_1.htm EX-4.1 174240
3 EX-4.2 hcwb-ex4_2.htm EX-4.2 166813
4 EX-4.3 hcwb-ex4_3.htm EX-4.3 163911
5 EX-10.1 hcwb-ex10_1.htm EX-10.1 192302
6 EX-10.2 hcwb-ex10_2.htm EX-10.2 354784
7 EX-10.3 hcwb-ex10_3.htm EX-10.3 18760
8 EX-99.1 hcwb-ex99_1.htm EX-99.1 19831
9 GRAPHIC img90053791_0.jpg GRAPHIC 137410
  Complete submission text file 0000950170-25-072700.txt   1633874

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT hcwb-20250513.xsd EX-101.SCH 24849
21 EXTRACTED XBRL INSTANCE DOCUMENT hcwb-20250513_htm.xml XML 4700
Mailing Address 2929 N COMMERCE PKWY MIRAMAR FL 33025
Business Address 2929 N COMMERCE PKWY MIRAMAR FL 33025 954-842-2024
HCW Biologics Inc. (Filer) CIK: 0001828673 (see all company filings)

EIN.: 825024477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40591 | Film No.: 25953801
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)